title: Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy.
authors: Department of Biological Chemistry, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel. billb@vms.huji.ac.il
authors: W
authors: W
authors: Breuer
authors: M J
authors: MJ
authors: Ermers
authors: P
authors: P
authors: Pootrakul
authors: A
authors: A
authors: Abramov
authors: C
authors: C
authors: Hershko
authors: Z I
authors: ZI
authors: Cabantchik
mesh_terms: D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use; D003676:Deferoxamine / Q000097:blood* / Q000494:pharmacology / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods*; D006486:Hemosiderosis / Q000097:blood* / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007501:Iron / Q000097:blood*; D065227:Transfusion Reaction
chemical_list: D002614:Chelating Agents; D007501:Iron; D003676:Deferoxamine